MSP Recovery, Inc. (NASDAQ: MSPR) — also known as LifeWallet — swung wildly in Tuesday’s pre‑market, at one point topping the list of healthcare gainers on heavy volume as investors weighed conflicting earnings‑calendar signals and the company’s ongoing bid to avert a Nasdaq delisting.
What happened today (Nov. 11, 2025)
- Pre‑market surge: By about 7:07 a.m. ET, Benzinga placed MSPR up ~93% to $0.61, ranking it among the biggest pre‑market movers in healthcare. [1]
- Multiple trackers show MSPR near the top of gainers: ChartMill’s live screen listed MSPR +76% to ~$0.56 in pre‑market, while StockAnalysis’ pre‑market board showed MSPR as the #1 gainer (~+77%) with ~59M pre‑market shares traded around $0.56. [2]
- But the tape was whipsawing: Earlier “before the bell” snapshots flagged double‑digit pre‑market losses (about ‑15.8%) in thin trade, underscoring the extreme volatility. AInvest’s 4:45 a.m. ET brief and a mid‑morning European roundup both referenced pressure ahead of the Q3 print. [3]
Bottom line: Depending on the timestamp, different pre‑market dashboards painted opposite pictures — a common quirk in micro‑cap names with surging off‑hours volume. Always check the latest prints and times attached to each data source.
Why the spike? Earnings calendar confusion + micro‑cap flows
- Earnings timing remains murky across calendars. TipRanks lists Q3 2025 results “Before Open (Confirmed)” on Wednesday, Nov. 12. Nasdaq’s earnings page, meanwhile, shows an estimated date of Thursday, Nov. 13, and MarketScreener had today (Nov. 11) marked as “Projected.” The lack of a fresh company press release leaves traders reliant on third‑party calendars — a recipe for outsized pre‑market swings. [4]
- Heavy pre‑market liquidity amplified moves. StockAnalysis showed ~59,002,994 MSPR shares changing hands pre‑market near $0.56, which can create rapid price gaps in either direction. [5]
Today’s snapshot (as of publication)
- Prior close (Mon., Nov. 10):$0.3170 on ~16.1M shares. [6]
- Pre‑market range discussed in headlines: roughly $0.52–$0.61, depending on the timestamp and outlet. [7]
(Note: Pre‑market prices are volatile and can change materially by the opening bell.)
Context: 2025 has been a reset year for LifeWallet/MSP Recovery
- Reverse stock split to keep bid above $1: On Aug. 28, the company approved a 1‑for‑7 reverse split effective after market close Sept. 1; split‑adjusted trading began Sept. 2. [8]
- Liquidity & balance‑sheet plan: On Apr. 10, MSPR announced a strategic term sheet with Hazel and Virage that aimed to cut $1.2B of corporate‑guaranteed debt, secure bridge funding, and establish a new servicing entity to focus on claim recoveries. [9]
- Yorkville financing tweaks & Nasdaq notice: An Oct. 22 Form 8‑K detailed a floor‑price reduction to $0.50 under the Yorkville SEPA, a $0.50M convertible‑note advance, and Nasdaq staff’s delisting determination (suspension slated Oct. 31 unless a hearing request stayed it). MSPR said it intended to request a hearing. [10]
Key takeaways for Nov. 11, 2025
- MSPR dominated pre‑market headlines as a top gainer on tens of millions of shares traded off‑hours; some trackers earlier showed losses, reflecting turbulence typical of micro‑caps ahead of potential catalysts. [11]
- Earnings timing remains inconsistent across widely used calendars (Nov. 12 before open vs. Nov. 13 estimate vs. Nov. 11 projected). Without a fresh company notice, traders are reacting to calendar chatter rather than firm guidance. [12]
- The bigger story hasn’t changed: the stock’s listing status, financing path, and restructuring milestones continue to frame sentiment and volatility. [13]
What to watch next
- Official Q3 release timing — Look for a company press release or IR update to reconcile the calendar discrepancies highlighted above. [14]
- Any update on the Nasdaq hearing — The Oct. 22 8‑K signaled an intent to appeal the delisting determination; outcomes here can be market‑moving. [15]
- Follow‑through volume after the open — Pre‑market surges often retrace if liquidity thins, but can extend if volume persists into regular trading. [16]
Sources published today (Nov. 11, 2025)
- Benzinga (7:07 a.m. ET): “12 Health Care Stocks Moving In Tuesday’s Pre‑Market Session” — MSPR +93% to $0.61. [17]
- ChartMill (ongoing update): “Top gainers and losers of Tuesday’s pre‑market session” — MSPR +76% to ~$0.56. [18]
- StockAnalysis pre‑market board:MSPR #1 gainer, ~+77%, ~59M pre‑market volume near $0.56. [19]
- AInvest (4:45 a.m. ET): “MSP Recovery Plunges 15.8%…” — highlighted early weakness before subsequent rebound. [20]
- Ad‑hoc‑news (11:09 CET): “MSP Recovery Shares Plunge Ahead of Earnings Release”. [21]
Additional official context:
- MSPR reverse split (Aug. 28, 2025); strategic term sheet (Apr. 10, 2025); Yorkville floor‑price cut & Nasdaq delisting notice (Oct. 22, 2025 8‑K). [22]
- Prior close & volume (Nov. 10, 2025):$0.3170, ~16.1M shares (Yahoo Finance historical). [23]
Editor’s note: Nothing herein is investment advice; micro‑cap stocks can be highly volatile.
References
1. www.benzinga.com, 2. www.chartmill.com, 3. www.ainvest.com, 4. www.tipranks.com, 5. stockanalysis.com, 6. finance.yahoo.com, 7. 247marketnews.com, 8. www.globenewswire.com, 9. www.globenewswire.com, 10. www.sec.gov, 11. stockanalysis.com, 12. www.tipranks.com, 13. www.sec.gov, 14. www.tipranks.com, 15. www.sec.gov, 16. stockanalysis.com, 17. www.benzinga.com, 18. www.chartmill.com, 19. stockanalysis.com, 20. www.ainvest.com, 21. www.ad-hoc-news.de, 22. www.globenewswire.com, 23. finance.yahoo.com
